openPR Logo
Press release

Joint Pain Injection Market is expected to reach US$ 6,996.88 million by 2028 With Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika

04-30-2021 04:30 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Joint Pain Injection Market

Joint Pain Injection Market

According to our new research study on “Joint Pain Injection Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Drug, Joint Type, and Distribution Channel,” the market is expected to reach US$ US$ 6,996.88 million by 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028. The report highlights trends prevailing in the joint pain injection market and factors driving its growth. The growth of the joint pain injection market is mainly attributed to the factors such as the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00003536/?openpr-10225

Based on drug, the joint pain injection market, by drug, is segmented into hyaluronic acid, corticosteroid, and others. The corticosteroid segment held the largest market share in 2020, and it is expected to register the highest CAGR during the forecast period. Corticosteroids offer quick pain relief and help treat inflammation, pain, swelling, and redness. Further, surge in number of product approvals and launches is a key factor contributing to the market growth of the corticosteroids segment. For instance, in 2017, FDA approved ZILRETTA, an extended-release corticosteroid for the treatment of osteoarthritis-related knee pain.

Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx are among the leading companies operating in the joint pain injection market.

The report segments the joint pain injection market as follows:

By Drug

Hyaluronic Acid
Corticosteroid
Others

By Joint Type

Knee
Foot and Ankle
Shoulder and Elbow
Hip
Others

By Distribution Channel

Retail Pharmacies
Hospitals Pharmacies
Others

By Geography

North America
US
Canada
Mexico

Europe
France
Germany
UK
Spain
Italy
Rest of Europe

Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of Asia Pacific

Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of Middle East and Africa

South and Central America (SCAM)
Brazil
Argentina
Rest of South and Central America

Interested in purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00003536/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Joint Pain Injection Market is expected to reach US$ 6,996.88 million by 2028 With Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika here

News-ID: 2278242 • Views:

More Releases from The Insight Partners

Global Self-Checkout System Market Driven by Retail Automation and AI Innovation
Global Self-Checkout System Market Driven by Retail Automation and AI Innovation
New York, US - October 16, 2025 - The Insight Partners has published its latest research report titled "Self-Checkout System Market Forecast to 2031 - Global Analysis by Component, Model Type, and End User." The study reveals that the Self-Checkout System Market is expected to grow at a CAGR of 8.2% from 2025 to 2031, driven by rapid retail automation, growing consumer demand for contactless experiences, and advances in AI
The Rising Tide: HPMC Capsule Market Overview
The Rising Tide: HPMC Capsule Market Overview
In recent years, the pharmaceutical, nutraceutical, and supplement industries have seen a clear shift toward plant based, non animal derived dosage forms. Among these, hydroxypropyl methyl cellulose (HPMC) capsules have emerged as a leading non gelatin alternative, largely driven by growing consumer preferences for vegetarian/vegan products, stricter regulatory trends, and technical advantages of HPMC over traditional gelatin shells. According to a market report by The Insight Partners, the global HPMC Capsule
Aesthetic Fillers and Exosomes Market Report: Unlocking Growth Potential and Addressing Challenges
Aesthetic Fillers and Exosomes Market Report: Unlocking Growth Potential and Add …
The Insight Partners is proud to announce its newest market report, "Aesthetic Fillers and Exosomes Market: An In-depth Analysis of the Global Aesthetic Fillers and Exosomes Market." The report provides a holistic view of the Aesthetic Fillers and Exosomes Market and describes the current scenario as well as growth estimates of the market during the forecast period. Check valuable insights in the Aesthetic Fillers and Exosomes Market report. You can easily
Understanding the Rheumatology Market: Segments & Scope
Understanding the Rheumatology Market: Segments & Scope
According to The Insight Partners, the rheumatology market is broadly segmented by: • Drug class: nonsteroidal anti inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and disease modifying anti rheumatic drugs (DMARDs). • Disease indications: rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis. • Distribution channels: hospital pharmacies, retail pharmacies, online pharmacies. • Geography: the usual regions (North America, Europe, Asia Pacific, South & Central America, etc.) with further country level breakdowns. CAGR (Compound Annual Growth

All 5 Releases


More Releases for Joint

"Joint Genesis Launches Revolutionary Natural Supplement for Joint Pain Relief & …
Joint Genesis has officially launched its breakthrough natural supplement designed to provide effective joint pain relief, improve mobility, and support long-term joint regeneration. This scientifically inspired formula combines powerful natural ingredients to help adults maintain an active lifestyle, reduce stiffness, and support overall joint health. Joint GenesisTM is ideal for anyone looking for a safe, natural alternative to traditional painkillers. Customers can purchase the supplement online at https://us-jointgenesisis.com and experience
Arthro MD+ Joint Support - Enhance Mobility And Joint Stability!
As we age or engage in physically demanding activities, our joints often take the brunt of the damage. Stiffness, pain, and reduced flexibility can limit mobility and affect our quality of life. This is where Arthro MD+ Joint Support comes into play. In this comprehensive guide, we will explore everything you need to know about this joint supplement, from its benefits to how it works, customer reviews, and more. By
Pharma Flex RX Joint Support™ Healthy Joint Mobility Flexibility!
Are you tired of living with joint pain, inflammation, and arthritis? Pharma Flex RX Joint Support is here to help. This is made to ease your joint pain and support your health. It uses natural ingredients that work together to fix the real causes of your joint pain. This means you can move freely and enjoy your life again. ● Product Name - Pharma Flex RX Joint Support ● Results - In
BioDynamix Joint Genesis - Time To Say Bye To Joint Pain (Joint Genesis Reviews)
What is BioDynamix Joint Genesis? BioDynamix Joint Genesis is a doctor-formulated supplement designed to treat joint pain and discomfort. The formula rejuvenates and restores your joints, offering a pain-free life. BioDynamix Joint Genesis ensures you enjoy flexibility, movement, and independence for a long time. It soothes all kinds of joint inflammation and combats stiffness. The formula works by addressing the underlying cause of joint issues. BioDynamix Joint Genesis works for adults between ages
Revolutionizing Sacroiliac Joint Treatment: Minimally Invasive Sacroiliac Joint …
Minimally Invasive Sacroiliac Joint Fusion (MIS-SIJ Fusion) is a surgical procedure for treating sacroiliac joint disorders, where the sacroiliac joint is stabilized through minimally invasive techniques. MIS sacroiliac joint fusion is a less invasive alternative to traditional open sacroiliac joint fusion and is gaining popularity among patients and healthcare providers. The MIS sacroiliac joint fusion market is expected to grow significantly in the coming years, driven by the increasing demand
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big